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 Objectives To review the latest evidence on antibiotic prophylaxis for 
patients with total joint replacements to prevent prosthesis 
infections.
 Data sources Literature search of Medline and PubMed until June 2009.
 Study selection Studies of patients with total joint replacements from around 
the world, studies concerning antibiotic prophylaxis, as well as 
chemoprophylaxis guidelines from orthopaedic associations 
were searched.
 Data extraction Literature review, original articles, case reports, best practice 
guidelines.
 Data synthesis With the rising incidence of patients with total joint replacements, 
subsequent deep infection of the implants is a rare but dreaded 
complication which has immense physiological, psychological, 
financial, and social implications. Guidelines from urologists, 
gastroenterologists, and dental surgeons attempt to identify 
high-risk patients who may be more susceptible to prosthetic 
joint infections. These patients are provided with prophylactic 
antibiotics before any invasive procedure that may cause bacterial 
seeding to prosthetic joints. Most orthopaedic associations 
around the world adopt a similar policy to provide prophylaxis 
to cover any anticipated chance of bacteraemia. The American 
Association of Orthopaedic Surgeons adopts the most cautious 
approach in which all patients with total joint replacements who 
undergo any procedure that breaches a mucosal surface receive 
prophylactic antibiotics.
 Conclusion The guidelines from the American Association of Orthopaedic 
Surgeons seem to have an all-encompassing policy when it comes 
to providing prophylactic antibiotics. Nonetheless, physicians 
must still exercise their judgement and customise the treatment 
to each patient. The benefits of prophylactic antibiotics must be 
balanced against the risks of drug side-effects and the emergence 
of antibiotic resistance.
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Introduction
With an ageing population, total joint replacements are becoming more common. In the 
United States, at least 400 000 total hip and knee replacements are performed every year; 
in Hong Kong the number approaches 2000 per year. One uncommon but devastating 
complication after joint replacement surgery is late infection of the prosthesis, which 
has extremely high cost implications. The guidelines on prophylactic antibiotics prior to 
joint replacement surgery to prevent postoperative infections are very clear. However, 
there are no clear guidelines on providing future chemoprophylaxis to cover subsequent 
invasive procedures to prevent late haematogenous infection in these patients. While 
the prescription of prophylactic antibiotics to prevent endocarditis in high-risk cardiac 
patients is quite clear, orthopaedic surgeons from around the world have differing opinions 
on prophylactic antibiotics for patients with prosthetic joints. In this review, the current 
evidence and data concerning this issue are discussed.
Bacteriology of infected joint replacements
Infection of the prosthetic joint can be classified as ‘early’, ‘delayed’, or ‘late’ according to 
the time of its onset. Early infections are defined as those that occur within 3 months of 
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關節置換術後抗生素的預防性應用
	 目的	 對接受關節置換術的病者，可施用抗生素以防假體感
染。本研究回顧相關的最新資料。
	 資料來源	 搜索至2009年6月於Medline及P u b M e d發表的文
獻。
	 研究選取	 檢索全球對關節置換術病例的研究，及骨科醫學會對
預防性抗生素應用的研究以及化學藥物預防的應用指
引。
	 資料選取	 文獻、原創論文、病例報告、常規應用指引。
	 資料綜合	 需要接受關節置換術的病人不斷增加，儘管隨後發
生植入體深層感染的情況並不多見，但卻是嚴重的
併發症，對患者身心健康、財政，以至對社會都有
所影響。泌尿外科、胃腸病學、牙科均設有指引，用
以識別可能較易出現人工關節術後感染的高危病人。
對這類患者，醫院在進行創傷性手術前，會先施用抗
生素，以防術中可能在人工關節處造成細菌繁殖。全
球大部分骨科醫學會採納類似的預防措施，以導絕菌
血症發生的機會，當中以美國骨科醫學會所採納的措
施最為謹慎，該會指引申明，對接受關節置換術的病
人，如手術會傷及黏膜表面的，都會採取預防性抗生
素應用的措施。
	 結論	 美國骨科醫學會的指引，對預防性抗生素應用採取
「包圍式」的策略，但應用時，醫生必須加以判
斷，因應患者的個別情況來醫治，要衡量應用預防
性抗生素所帶來的好處，以及藥物的副作用和抗生
素抗藥性的弊端之間的平衡。
surgery and delayed infections are those occurring 
3 to 24 months after surgery.1,2 It is commonly 
assumed that these are due to the operation itself 
for which preoperative prophylactic antibiotics 
are given. Late infections are largely attributed to 
haematogenous spread of bacteria from other sites 
of the body. Fortunately, they are uncommon and 
are quoted to ensue in less than 1% of patients with 
hip replacements, and less than 2% of patients with 
knee replacements.3 However, the cost of treating 
a ‘late-infected’ prosthesis is prohibitive and it is 
for this condition that we investigate whether or 
not prophylactic antibiotics are of any use. Of 578 
patients with late-infected joint replacements at the 
Mayo Clinic, 53% were due to staphylococci, 9% to 
streptococci, 6% to Gram-negative organisms, and 
4% to anaerobes.4 From this, it can be deduced that 
the sources of bacteria are from the skin, respiratory, 
gastro-intestinal, and urogenital tracts. The life-
time risk of haematogenous infection of prosthetic 
joints due to Staphylococcus bacteraemia has been 
estimated to be as high as 34%.5
Dental treatment
Reviews in the literature revealed that 6 to 11% of all 
cases of infected prosthetic joints can be attributable to 
dental procedures.6,7 The bacteria isolated from blood 
cultures following dental work are mainly viridans 
streptococci, Gemella spp, Peptostreptococcus 
spp, Neisseria spp, Actinomyces spp, Prevotella 
spp, and other anaerobes. However, routine daily 
activities such as tooth-brushing and even chewing 
produce even greater degrees of bacteraemia than 
dental procedures.8 It is reasoned that the risks of 
spontaneous bacteraemia from poor oral hygiene 
and periodontitis pose a greater risk than routine 
dental operations. Therefore, the American Dental 
Association has stated that antibiotic prophylaxis 
is not mandatory for routine dental procedures in 
patients with prosthetic joints. Antibiotics should 
only be given for patients who are considered at 
increased risk for infection. These include joint 
replacement surgery done within the past 2 years, 
previous infection of a prosthetic joint, inflammatory 
arthritis, type 1 diabetes mellitus, haemophilia, 
immunosuppression, a history of previous or current 
malignancy, dental extraction, periodontal procedures, 
dental implantation, root canal work, descaling 
if bleeding is anticipated, specialised injections 
of local anaesthetic, or placement of orthodontic 
bands.9 For these patients, amoxicillin or ampicillin 
2 g, a first- or second-generation cephalosporin, 
or clindamycin 600 mg given orally 1 hour before 
the dental procedure is adequate. A second dose 
is seldom needed. The Australian Orthopaedic 
Association, British Orthopaedic Association, Swiss 
Society for Infectious Diseases,10 and New Zealand 
Orthopaedic Association11 have all made very similar 
suggestions for prescribing prophylactic antibiotics 
only for patients at an increased risk of infection. For 
their respective risk factor lists, the corresponding 
guideline of each association should be referred to. 
 Joint replacement surgery performed within 
2 years seems to be an often-quoted risk for deep 
infection based on the theoretical reason that 
the postoperative period confers a degree of 
inflammation which increases the blood flow to the 
prosthetic joint. This is assumed to carry an increased 
risk of haematogenous spread of infection. This was 
apparently so in the series reported by LaPorte et al7 
in which 50% of dentistry-associated prosthetic joint 
infections occurred within 2 years of the index joint 
replacement surgery. However, this is not always the 
case as illustrated in a study done by Waldman et 
al in 1997 in which late joint infections after dental 
procedures were also analysed.6 In this study, ‘late’ 
infections were defined as deep infections which 
developed more than 6 months after the index joint 
replacement surgery; onset of infections after joint 
replacement ranged from 26 to 95 months, with a 
mean of 72 months. Thus, none of these infections 
ensued within the presumed high-risk period of 
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2 years. We would therefore question whether or 
not an increased infection risk in the immediate 
postoperative period is a valid assumption.
 While dental associations attempt to identify 
high-risk patients for the prescription of prophylactic 
antibiotics, the American Academy of Orthopaedic 
Surgeons published a more inclusive guideline in 
2009. Further details can be accessed via their “latest 
recommendations” section.12
Urological interventions
Any procedure that involves breeching the urological 
tract is considered clean-contaminated surgery. The 
likelihood of bacteraemia increases if bacteriuria 
is present.13 In a prospective study by Girou et al14 
of 284 patients who underwent prostatectomies, 
transurethral resection, and open urological surgery, 
22% who had sterile urine cultures preoperatively 
developed bacteriuria postoperatively. Bacteraemia 
subsequently developed in one patient. Dabasia et 
al15 reported the case of a patient who developed 
an Enterococcus faecalis infection of his total hip 
replacement after undergoing a transurethral 
resection of the prostate without prophylactic 
antibiotics. According to the American Urological 
Association (AUA), patients fulfilling two criteria—
namely (1) increased risk of haematogenous total 
joint infection, and (2) increased risk of bacteraemia 
associated with urologic procedures—should be 
given prophylactic antibiotics (Table 1). The antibiotic 
that should be given is a single dose of quinolone 
orally 1 to 2 hours preoperatively, or intravenous 
(IV) ampicillin 2 g plus gentamicin 1.5 mg/kg 30 to 
60 minutes preoperatively. For those who do not 
meet both sets of criteria, the AUA recommends 
that the surgeon uses his or her discretion for each 
patient.13
 While urological associations attempt to 
identify patients with high risk of joint infections 
before prescribing prophylactic antibiotics, the 
American Academy of Orthopaedic Surgeons recently 
issued more inclusive guidelines in 2009. These can 
be accessed via their “latest recommendations” 
section.12
Gastro-intestinal endoscopic procedures
There are case reports of patients who developed 
infections of their knee replacements after a 
colonoscopy.16,17 It has been estimated that 1.9% of 
patients with late infection of prosthetic joints are 
due to endoscopic procedures.18 Any procedure 
that breeches the alimentary tract under controlled 
conditions and without unusual contamination 
is considered clean-contaminated surgery. Gross 
spillage from the gastro-intestinal tract would 
render it to be contaminated surgery. Previous 
studies have found bacteraemia in up to 5% of 
upper endoscopies, 5% of sigmoidoscopies, and 
8% of colonoscopies.19,20 However, these numbers 
have recently been challenged as they are similar to 
rates of contamination of blood cultures (4-12%).21 
Understandably, the rates of bacteraemia increase 
as endoscopies are accompanied by procedures 
such as biopsy or polypectomy. The highest rate of 
bacteraemias (approaching 45%) was encountered in 
dilatation of oesophageal strictures and sclerotherapy 
of oesophageal varices.19 According to the guidelines 
set by the American Society for Gastrointestinal 
Endoscopy in 2008,22 there are still no clear data to 
support the use of prophylactic antibiotics in patients 
with prosthetic joints. Therefore, prophylactic 
antibiotics are not recommended in these patients 
prior to gastro-intestinal endoscopic procedures.22 
As for formal gastro-intestinal surgeries, the usual 
prophylactic antibiotics are given as for any other 
patients. 
 From the literature, prophylactic antibiotics are 
not recommended for patients with prosthetic joints 
undergoing endoscopic procedures. In 2009 however, 
the American Academy of Orthopaedic Surgeons 
issued guidelines which are far more inclusive. These 
Increased risk of haematogenous 
total joint infection
Increased risk of bacteraemia 
associated with urological procedures
Patients during the first 2 years after 
prosthetic joint replacement
Any stone manipulation (includes 
shock-wave lithotripsy)
Immunocompromised patients with 
prosthetic joint replacements
• Inflammatory arthropathies (eg 
rheumatoid arthritis, systemic lupus 
erythematosus)
• Drug-induced immunosuppression
• Radiation-induced 
immunosuppression
Any procedure with transmural 
incision into urinary tract (does not 
include simple ligation with excision or 
percutaneous drainage procedure)
Patients with prosthetic joint 
replacements and co-morbidities
• Previous prosthetic joint infections
• Malnourishment
• Haemophilia
• HIV infection
• Diabetes
• Malignancy
Any endoscopic procedures of upper 
tract (kidney and ureter)
Any procedure that includes bowel 
segments
Transrectal prostate biopsy
Any procedure with entry into the 
urinary tract (except for urethral 
catheterization) in individuals with 
higher risk of bacterial colonisation:
• Indwelling catheter or intermittent 
catheterization
• Indwelling ureteral stent
• Urinary retention
• History of recent/recurrent urinary 
tract infection or prostatitis
• Urinary diversion
TABLE 1. Risk factors for patients with prosthetic joints undergoing urological 
procedures (adapted from Best Practice Policy from American Urological Association, 
200813)
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are detailed in the next section.
Latest recommendations
The prevention of haematogenous spread of bacterial 
infection to prosthetic joints has often been likened 
to antibiotic prophylaxis for endocarditis in high-risk 
cardiac patients. However, the differences between 
these two conditions in terms of anatomy, blood supply, 
microorganisms, and mechanisms of infection are so 
great that this analogy should not be made.23 Given 
the huge costs associated with treating an infected 
joint replacement, the latest recommendation from 
the American Association of Orthopaedic Surgeons in 
2009 suggests antibiotic prophylaxis for all total joint 
replacement patients prior to any invasive procedure 
that may cause bacteraemia.12 A single pre-procedure 
dose is usually sufficient and the antibiotic should 
be discontinued 24 hours thereafter. Extra attention 
must be paid to patients with the following risk 
factors: immunocompromised/immunosuppressed 
state (drug- or radiation-induced), inflammatory 
arthropathy (eg rheumatoid arthritis, systemic 
lupus erythematosus), co-morbidities (eg obesity, 
smoking), previous prosthetic joint infections, 
malnourishment, haemophilia, HIV infection, type 
1 diabetes, malignancy, and megaprosthesis.12 Table 
2 lists the recommended antibiotics to be used. The 
website of the American Academy of Orthopaedic 
Surgeons12 can be referred for more details about 
suggested antibiotic cover for invasive procedures 
in subspecialties such as obstetrics and gynaecology, 
ophthalmology, head and neck, and vascular surgery. 
 In addition to the myriad of guidelines, 
clinicians must evaluate each patient individually and 
balance the benefits of antibiotic prophylaxis with the 
risks of increasing bacterial resistance, adverse side-
effects, and drug interactions. Antibiotic-associated 
infections such as Clostridium difficile colitis have 
also been quoted as a caveat to consider before 
prescribing prophylactic antibiotics,24 though this 
risk appears unrealistic as typically only a single dose 
of a narrow-spectrum agent is prescribed.
Our practice
Our guidelines are quite similar to those of the 
American Academy of Orthopaedic Surgeons. We 
advise that patients with prosthetic joints should 
receive a single dose of oral amoxicillin 2 g 2 to 
3 hours prior to any dental procedure. For those 
undergoing urological procedures, a single dose of 
oral ciprofloxacin 500 mg or IV ciprofloxacin 400 mg 
should be given 1 hour prior to the procedure. For 
patients undergoing urological procedures via the 
transrectal approach, the prophylaxis should cover 
bowel flora. Patients undergoing upper endoscopies 
should be given a single IV dose of cefazolin 
1 g 1 hour prior to the endoscopy. For patients 
undergoing sigmoidoscopies or colonoscopies, 
overseas literature supports the use of a single dose 
of oral metronidazole 1 g given 1 hour prior to the 
endoscopy. Although there are no local guidelines 
for endoscopic procedures, the guidelines from 
IMPACT (Interhospital Multi-disciplinary Programme 
on Antimicrobial ChemoTherapy25) advise a dose of 
IV cefuroxime 1.5 g and a dose of IV metronidazole 
500 mg to be given to all patients prior to elective 
colorectal surgeries. For patients with allergies to 
the aforementioned antibiotics, consultation with 
microbiologists may be advisable for advice on 
appropriate alternatives. Individual considerations 
must be made for each patient. In circumstances 
where the use of antibiotics is unclear, discussion 
with the local microbiologist is advised. 
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